Issuu on Google+


CHALLENGES

ISSUE

MERCK

PROMISE

INNOVATIONS

THE NEW MERCK WAY


CHALLENGES

ISSUE

MERCK

PROMISE

INNOVATIONS

"I will not be ashamed to say "I know not", nor will I fail to call in my colleagues when the skills of another are needed for a patient's recovery." Excerpt from the Hippocratic Oath (modern version by Dr. Louis Lasagna, 1964)


CHALLENGES

Challenges - Rapid growth of generic drug industry.

ISSUE

- Expansion into international sectors and emerging markets. - Merck has recently slipped from the 2nd largest to 6th largest pharmaceutical company.

MERCK - Recent legislation has restricted interaction with physicians, pharmaceutical representatives, and pharmaceutical companies.

PROMISE

INNOVATIONS

- Merck is only a leader in their HPV vaccine treatment, their patent expires in 6 years.


CHALLENGES

ISSUE

“In this age, all of us have smart phones, why can’t they have an app where there is a live rep to answer my questions?”

MERCK

“It´s the drugs that matter not who makes them.”

PROMISE

“Merck is a pioneer”

INNOVATIONS

“Merck is an elephant”


CHALLENGES

ISSUE

MERCK

PROMISE

INNOVATIONS

QUIET CLOSE MINDED POWERFUL OVERWEIGHT CREATOR ORDINARY


CHALLENGES

ISSUE

MERCK

PROMISE

1891 1899 The first Merck Manual is published to serve as a guide to physicians and pharmacists. Today, this Manual is published in 17 languages.

INNOVATIONS


CHALLENGES

ISSUE

MERCK

PROMISE

INNOVATIONS


CHALLENGES

ISSUE

MERCK

PROMISE

INNOVATIONS

Promise Merck has focused greatly on content and not learning, as part of Merck’s new promise we will take this incredible content and create an educational and interactive learning environment for physicians. We will transform the information of the Merck Manual into a visual experience evolving through innovative technologies and more personalized interactions.


CHALLENGES

ISSUE

MERCK

PROMISE

INNOVATIONS

Character

QUIET CLOSE MINDED SUPPORTIVE POWERFUL OVERWEIGHT VISIONARY CREATOR ORDINARY SCIENTIST


CHALLENGES

ISSUE

MERCK

PROMISE

INNOVATIONS

EMPOWERING DOCTORS TO MAKE A DIFFERENCE


CHALLENGES

ISSUE

MERCK

PROMISE

INNOVATIONS

VISUAL VOCABULARY


CHALLENGES

ISSUE

MERCK

PROMISE

INNOVATIONS


CHALLENGES

ISSUE

MERCK

PROMISE

INNOVATIONS


CHALLENGES

ISSUE

MERCK

PROMISE

INNOVATIONS


CHALLENGES

ISSUE

MERCK

PROMISE

INNOVATIONS


CHALLENGES

PRINZIDE 10-12.5 (Lisinopropil-Hydrochlorothiazide) 速

ISSUE

100 Tablets

Each tablet contains 10 mg lisinopril and 12.5 mg hydrochlorothizide 145

MERCK

PROMISE

INNOVATIONS

NDC 0006-0145-58 Store at controlled room temperature,

USUAL ADULT DOSAGE:

Rx only


CHALLENGES

ISSUE

MERCK

PROMISE

INNOVATIONS


CHALLENGES

ISSUE

MERCK

PROMISE

INNOVATIONS

MERCKSCENE APP


CHALLENGES

ISSUE

MERCK

PROMISE

INNOVATIONS


CHALLENGES

ISSUE

MERCK

PROMISE

INNOVATIONS


CHALLENGES

ISSUE

MERCK

PROMISE

INNOVATIONS


CHALLENGES

ISSUE

MERCK

PROMISE

INNOVATIONS


CHALLENGES

ISSUE

MERCK

PROMISE

INNOVATIONS



MERCK